1.
Breccia M, Girmenia C, Latagliata R, Loglisci G, Santopietro M, Federico V, et al. LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE. Mediterr J Hematol Infect Dis [Internet]. 2011 May 16 [cited 2024 Mar. 29];3(1):e2011021. Available from: https://www.mjhid.org/mjhid/article/view/2011.021